The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

R. Iacovelli; M. Cossu Rocca; L. Galli; R. Sabbatini; U. De Giorgi; D. Santini; G. Facchini; A. Mosca; F. Atzori; P. Zucali; G. Fornarini; F. Massari; S. Buti; R. Ricotta; C. Masini; I. Toscani; E. Biasco; A. Guida; C. Lolli; D. De Lisi; S. Rossetti; C. Terrone; M. Scartozzi; C. Miggiano; A. Pastorino; M. Bersanelli; G. Carlo-Stella; C. Pinto; E. Nobili; F. Nolè; G. Tortora; C. Porta

doi:10.1097/CAD.0000000000000632

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

R. Iacovelli, M. Cossu Rocca, L. Galli, R. Sabbatini, U. De Giorgi, D. Santini, G. Facchini, A. Mosca, F. Atzori, P. Zucali, G. Fornarini, F. Massari, S. Buti, R. Ricotta, C. Masini, I. Toscani, E. Biasco, A. Guida, C. Lolli, D. De LisiS. Rossetti, C. Terrone, M. Scartozzi, C. Miggiano, A. Pastorino, M. Bersanelli, G. Carlo-Stella, C. Pinto, E. Nobili, F. Nolè, G. Tortora, C. Porta

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	705-709
Number of pages	5
Journal	Anti-Cancer Drugs
Volume	29
Issue number	7
DOIs	https://doi.org/10.1097/CAD.0000000000000632
Publication status	Published - 2018

Access to Document

10.1097/CAD.0000000000000632

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050610189&doi=10.1097%2fCAD.0000000000000632&partnerID=40&md5=1f184f12ee80512a2ff6a5af4bc3e405

Cite this

Iacovelli, R., Cossu Rocca, M., Galli, L., Sabbatini, R., De Giorgi, U., Santini, D., Facchini, G., Mosca, A., Atzori, F., Zucali, P., Fornarini, G., Massari, F., Buti, S., Ricotta, R., Masini, C., Toscani, I., Biasco, E., Guida, A., Lolli, C., ... Porta, C. (2018). The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma. Anti-Cancer Drugs, 29(7), 705-709. https://doi.org/10.1097/CAD.0000000000000632

Iacovelli, R , Cossu Rocca, M , Galli, L, Sabbatini, R, De Giorgi, U, Santini, D, Facchini, G , Mosca, A, Atzori, F, Zucali, P , Fornarini, G, Massari, F, Buti, S, Ricotta, R, Masini, C, Toscani, I, Biasco, E, Guida, A , Lolli, C, De Lisi, D, Rossetti, S, Terrone, C, Scartozzi, M, Miggiano, C, Pastorino, A, Bersanelli, M, Carlo-Stella, G, Pinto, C, Nobili, E, Nolè, F , Tortora, G & Porta, C 2018, 'The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma', Anti-Cancer Drugs, vol. 29, no. 7, pp. 705-709. https://doi.org/10.1097/CAD.0000000000000632

@article{6ecc2a80e651436dabdc65c20204c5bc,

title = "The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma",

author = "R. Iacovelli and {Cossu Rocca}, M. and L. Galli and R. Sabbatini and {De Giorgi}, U. and D. Santini and G. Facchini and A. Mosca and F. Atzori and P. Zucali and G. Fornarini and F. Massari and S. Buti and R. Ricotta and C. Masini and I. Toscani and E. Biasco and A. Guida and C. Lolli and {De Lisi}, D. and S. Rossetti and C. Terrone and M. Scartozzi and C. Miggiano and A. Pastorino and M. Bersanelli and G. Carlo-Stella and C. Pinto and E. Nobili and F. Nol{\`e} and G. Tortora and C. Porta",

note = "Cited By :1 Export Date: 24 January 2019",

year = "2018",

doi = "10.1097/CAD.0000000000000632",

language = "English",

volume = "29",

pages = "705--709",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

AU - Iacovelli, R.

AU - Cossu Rocca, M.

AU - Galli, L.

AU - Sabbatini, R.

AU - De Giorgi, U.

AU - Santini, D.

AU - Facchini, G.

AU - Mosca, A.

AU - Atzori, F.

AU - Zucali, P.

AU - Fornarini, G.

AU - Massari, F.

AU - Buti, S.

AU - Ricotta, R.

AU - Masini, C.

AU - Toscani, I.

AU - Biasco, E.

AU - Guida, A.

AU - Lolli, C.

AU - De Lisi, D.

AU - Rossetti, S.

AU - Terrone, C.

AU - Scartozzi, M.

AU - Miggiano, C.

AU - Pastorino, A.

AU - Bersanelli, M.

AU - Carlo-Stella, G.

AU - Pinto, C.

AU - Nobili, E.

AU - Nolè, F.

AU - Tortora, G.

AU - Porta, C.

N1 - Cited By :1 Export Date: 24 January 2019

PY - 2018

Y1 - 2018

U2 - 10.1097/CAD.0000000000000632

DO - 10.1097/CAD.0000000000000632

M3 - Article

SN - 0959-4973

VL - 29

SP - 705

EP - 709

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 7

ER -